Does prophylactic substrate-based catheter ablation reduce the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death?
Prophylactic substrate-based catheter ablation reduces the incidence of ICD therapy in patients with prior MI receiving ICDs for secondary prevention.
In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 controlled-trials.com.).
Reddy et al. (2007) studied this question.